| P50 | author | Ghada Abu-Sheasha | Q91527779 |
| | Saba El-Gendi | Q96184730 |
| P2093 | author name string | Ghada Abu-Sheasha | |
| | Saba El-Gendi | |
| P2860 | cites work | Patterns of multiple recurrences of superficial (Ta/T1) transitional cell carcinoma of bladder and effects of clinicopathologic and biochemical factors | Q59706184 |
| | Molecular and Immunohistochemical Analysis of the Prognostic Value of Cell-Cycle Regulators in Urothelial Neoplasms of the Bladder | Q60050251 |
| | Ki-67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification | Q61022916 |
| | Immunohistochemical detection of p53 protein overexpression versus gene sequencing in urinary bladder carcinomas. | Q64904812 |
| | Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification | Q71061814 |
| | Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features | Q73048637 |
| | Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder | Q73535314 |
| | Frequent alteration of p63 expression in human primary bladder carcinomas | Q74052241 |
| | Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladder | Q74115915 |
| | Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma | Q77302627 |
| | Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort | Q77346920 |
| | Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome | Q77537658 |
| | Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer | Q77976619 |
| | The Role of p63 and p73 in tumor formation and progression: coming of age toward clinical usefulness. Commentary re: F. Koga et al., Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma | Q79342613 |
| | Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters | Q80552944 |
| | How well can you actually predict which non-muscle-invasive bladder cancer patients will progress? | Q84378950 |
| | Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC | Q86989619 |
| | Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma | Q95800968 |
| | Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II | Q28202289 |
| | Cycling to cancer with cyclin D1 | Q28214862 |
| | Tissue microarrays for high-throughput molecular profiling of tumor specimens | Q29618675 |
| | An introduction to recursive partitioning: rationale, application, and characteristics of classification and regression trees, bagging, and random forests | Q30496268 |
| | Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration | Q30514241 |
| | D-type cyclins in superficial and muscle-invasive bladder urothelial carcinoma: correlation with clinicopathological data and prognostic significance | Q33533392 |
| | Multivariate analysis of the prognostic factors of primary superficial bladder cancer | Q33799104 |
| | p63 expression defines a lethal subset of muscle-invasive bladder cancers | Q34131185 |
| | Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. | Q34280864 |
| | p53 Status correlates with the risk of recurrence in non-muscle invasive bladder cancers treated with Bacillus Calmette-Guérin: a meta-analysis | Q35572365 |
| | Control of apoptosis by p53. | Q35603381 |
| | Loss of p63 expression is associated with tumor progression in bladder cancer | Q35789205 |
| | Transcriptional regulation of the cyclin D1 gene at a glance | Q35985157 |
| | P53 as a prognostic marker for bladder cancer: a meta-analysis and review. | Q36243745 |
| | Immunohistochemical evaluation of cell cycle regulators: impact on predicting prognosis in stage t1 urinary bladder cancer | Q36470349 |
| | Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67. | Q36622503 |
| | Statistical strategies for constructing health risk models with multiple pollutants and their interactions: possible choices and comparisons | Q37379520 |
| | Cyclin D1 protein overexpression is related to tumor differentiation, but not to tumor progression or proliferative activity, in transitional cell carcinoma of the bladder | Q38471118 |
| | Toward a molecular pathologic classification of urothelial carcinoma. | Q42440945 |
| | The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates | Q42451765 |
| | p63 expression profiles in human normal and tumor tissues | Q42517203 |
| | Ki67 and TP53 expressions predict recurrence of non-muscle-invasive bladder cancer. | Q43423183 |
| | Predicting prognosis in patients with superficial bladder cancer. | Q43681304 |
| | Immunohistochemical expression of p63, p53 in urinary bladder carcinoma. | Q43889785 |
| | Cell-cycle regulators and the Ki-67 labeling index can predict the response to chemoradiotherapy and the survival of patients with locally advanced squamous cell carcinoma of the esophagus | Q44538177 |
| | Overexpression of cyclin D1 correlates with sensitivity to cisplatin in squamous cell carcinoma cell lines of the head and neck. | Q45106738 |
| | Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model. | Q45816848 |
| | Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer | Q45897988 |
| | Cyclin D1 and prognosis in human breast cancer | Q47335186 |
| | Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1). | Q47770673 |
| | Conservative management of low risk superficial bladder tumors | Q48548171 |
| | Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer. | Q53316763 |
| | Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma. A tissue microarray study of 158 cases. | Q53352582 |
| | Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis. | Q53601758 |
| | Cancer Incidence in Five Continents. Classification | Q53852048 |
| | P16, c-erbB2 and Ki67 immunoexpression in urothelial carcinomas of the bladder. | Q54583700 |
| P433 | issue | 2 | |
| P304 | page(s) | 309-322 | |
| P577 | publication date | 2017-05-09 | |
| P1433 | published in | Pathology Oncology Research | Q26842743 |
| P1476 | title | Ki-67 and Cell Cycle Regulators p53, p63 and cyclinD1 as Prognostic Markers for Recurrence/ Progression of Bladder Urothelial Carcinoma | |
| P478 | volume | 24 | |